IDEXX LABORATORIES INC /DE Notes Receivable, Related Parties, Noncurrent
IDEXX LABORATORIES INC /DE (IDXX) had Notes Receivable, Related Parties, Noncurrent of $5.20 million as of 2014-03-31, per its 10-Q filed 2014-04-25.
Discontinued › Notes › Receivables
us-gaap:NotesReceivableRelatedPartiesNoncurrent · last filed 2014-10-24
- 2014-03-31: Notes Receivable, Related Parties, Noncurrent $5.20M.
- 2013-12-31: Notes Receivable, Related Parties, Noncurrent $5.10M.
- 2013-09-30: Notes Receivable, Related Parties, Noncurrent $4.90M.
- 2013-06-30: Notes Receivable, Related Parties, Noncurrent $4.80M.
| Period end | Notes Receivable, Related Parties, Noncurrent |
|---|---|
| 2014-03-31 | $5.20M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $5.10M 10-Q · filed 2014-10-24 |
| 2013-09-30 | $4.90M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $4.80M 10-Q · filed 2013-07-23 |
| 2013-03-31 | $4.70M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $4.60M 10-K · filed 2013-02-19 |
| 2012-09-30 | $4.50M 10-Q · filed 2012-10-19 |
| 2012-06-30 | $4.40M 10-Q · filed 2012-07-20 |
| 2012-03-31 | $4.10M 10-Q · filed 2012-04-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |